|
|
Blood, 1 May 2004, Vol. 103, No. 9, pp. 3428-3430.
Prepublished online as a Blood First Edition Paper on December 18, 2003; DOI 10.1182/blood-2003-07-2598.
Previous Article | Table of Contents | Next Article 
IMMUNOBIOLOGY
CD4+CD25+ regulatory T-cell deficiency in patients with hepatitis C-mixed cryoglobulinemia vasculitis
Olivier Boyer,
David Saadoun,
Julien Abriol,
Mélanie Dodille,
Jean-Charles Piette,
Patrice Cacoub, and
David Klatzmann
From the Laboratoire de Biologie et Thérapeutique des Pathologies Immunitaires, CNRS/UPMC UMR 7087 and Service de Médecine Interne, Hôpital Pitié-Salpêtrière, Paris, France.
Patients who are chronically infected with hepatitis C virus (HCV) often develop mixed cryoglobulinemia (MC), a B-cell proliferative disorder with polyclonal activation and autoantibody production. We investigated if MC is associated with a deficit of CD4+CD25+ immunoregulatory T (Treg) cells, which have been shown to control autoimmunity. Because Treg cells express higher amounts of CD25 than activated CD4+ T cells, we analyzed blood CD4+CD25high Treg cells in 69 untreated patients chronically infected with HCV. Treg cell frequency in patients without MC (8.8% ± 2.3%) or with asymptomatic MC (7.4% ± 2.1%) was comparable to that of healthy controls (7.9% ± 1.3%). In contrast, it was significantly reduced in symptomatic MC patients (2.6% ± 1.2%, P < .001) even when compared to a panel of untreated HCV- patients with different inflammatory disorders (6.2% ± 0.8%, P < .0001). In symptomatic MC patients, the purified remaining CD4+CD25+ T cells retained suppressive activity in vitro. These results, together with experimental data showing that depletion of Treg cells induces autoimmunity, suggest a major role of Treg cell deficiency in HCV-MC vasculitis and this is the first report of a quantitative Treg cell deficiency in virus-associated autoimmunity. (Blood. 2004; 103:3428-3430)

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
I. Kotsianidis, E. Nakou, I. Bouchliou, A. Tzouvelekis, E. Spanoudakis, P. Steiropoulos, I. Sotiriou, V. Aidinis, D. Margaritis, C. Tsatalas, et al.
Global Impairment of CD4+CD25+FOXP3+ Regulatory T Cells in Idiopathic Pulmonary Fibrosis
Am. J. Respir. Crit. Care Med.,
June 15, 2009;
179(12):
1121 - 1130.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Liu, N. Gong, X. Huang, A. D. Reynolds, R. L. Mosley, and H. E. Gendelman
Neuromodulatory Activities of CD4+CD25+ Regulatory T Cells in a Murine Model of HIV-1-Associated Neurodegeneration
J. Immunol.,
March 15, 2009;
182(6):
3855 - 3865.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D-A Landau, M Rosenzwajg, D Saadoun, D Klatzmann, and P Cacoub
The B lymphocyte stimulator receptor-ligand system in hepatitis C virus-induced B cell clonal disorders
Ann Rheum Dis,
March 1, 2009;
68(3):
337 - 344.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Korporal, J. Haas, B. Balint, B. Fritzsching, A. Schwarz, S. Moeller, B. Fritz, E. Suri-Payer, and B. Wildemann
Interferon Beta-Induced Restoration of Regulatory T-Cell Function in Multiple Sclerosis Is Prompted by an Increase in Newly Generated Naive Regulatory T Cells
Arch Neurol,
November 1, 2008;
65(11):
1434 - 1439.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Q. Jiang, L. Zhang, R. Wang, J. Jeffrey, M. L. Washburn, D. Brouwer, S. Barbour, G. I. Kovalev, D. Unutmaz, and L. Su
FoxP3+CD4+ regulatory T cells play an important role in acute HIV-1 infection in humanized Rag2-/-{gamma}C-/- mice in vivo
Blood,
October 1, 2008;
112(7):
2858 - 2868.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Dolganiuc and G. Szabo
T cells with regulatory activity in hepatitis C virus infection: what we know and what we don't
J. Leukoc. Biol.,
September 1, 2008;
84(3):
614 - 622.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Sansonno, F. A. Tucci, L. Troiani, G. Lauletta, M. Montrone, V. Conteduca, L. Sansonno, and F. Dammacco
Increased serum levels of the chemokine CXCL13 and up-regulation of its gene expression are distinctive features of HCV-related cryoglobulinemia and correlate with active cutaneous vasculitis
Blood,
September 1, 2008;
112(5):
1620 - 1627.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Bonelli, A. Savitskaya, K. von Dalwigk, C. W. Steiner, D. Aletaha, J. S. Smolen, and C. Scheinecker
Quantitative and qualitative deficiencies of regulatory T cells in patients with systemic lupus erythematosus (SLE)
Int. Immunol.,
July 1, 2008;
20(7):
861 - 868.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Saadoun, M. Rosenzwajg, D. Landau, J. C. Piette, D. Klatzmann, and P. Cacoub
Restoration of peripheral immune homeostasis after rituximab in mixed cryoglobulinemia vasculitis
Blood,
June 1, 2008;
111(11):
5334 - 5341.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M Bonelli, K von Dalwigk, A Savitskaya, J S Smolen, and C Scheinecker
Foxp3 expression in CD4+ T cells of patients with systemic lupus erythematosus: a comparative phenotypic analysis
Ann Rheum Dis,
May 1, 2008;
67(5):
664 - 671.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. C. Ndhlovu, C. P. Loo, G. Spotts, D. F. Nixon, and F. M. Hecht
FOXP3 expressing CD127lo CD4+ T cells inversely correlate with CD38+ CD8+ T cell activation levels in primary HIV-1 infection
J. Leukoc. Biol.,
February 1, 2008;
83(2):
254 - 262.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. H. Nguyen, S. Shashidhar, D. S. Chang, L. Ho, N. Kambham, M. Bachmann, J. M. Brown, and R. S. Negrin
The impact of regulatory T cells on T-cell immunity following hematopoietic cell transplantation
Blood,
January 15, 2008;
111(2):
945 - 953.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Li, E. J. Gowans, C. Chougnet, M. Plebanski, and U. Dittmer
Natural Regulatory T Cells and Persistent Viral Infection
J. Virol.,
January 1, 2008;
82(1):
21 - 30.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. Racanelli, M. A. Frassanito, P. Leone, C. Brunetti, S. Ruggieri, and F. Dammacco
Bone Marrow of Persistently Hepatitis C Virus-Infected Individuals Accumulates Memory CD8+ T Cells Specific for Current and Historical Viral Antigens: A Study in Patients with Benign Hematological Disorders
J. Immunol.,
October 15, 2007;
179(8):
5387 - 5398.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Saadoun, D. A. Landau, L. H. Calabrese, and P. P. Cacoub
Hepatitis C-associated mixed cryoglobulinaemia: a crossroad between autoimmunity and lymphoproliferation
Rheumatology,
August 1, 2007;
46(8):
1234 - 1242.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Haas, B. Fritzsching, P. Trubswetter, M. Korporal, L. Milkova, B. Fritz, D. Vobis, P. H. Krammer, E. Suri-Payer, and B. Wildemann
Prevalence of Newly Generated Naive Regulatory T Cells (Treg) Is Critical for Treg Suppressive Function and Determines Treg Dysfunction in Multiple Sclerosis
J. Immunol.,
July 15, 2007;
179(2):
1322 - 1330.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Holmes, G. Knudsen, S. Mackey-Cushman, and L. Su
FoxP3 Enhances HIV-1 Gene Expression by Modulating NF{kappa}B Occupancy at the Long Terminal Repeat in Human T Cells
J. Biol. Chem.,
June 1, 2007;
282(22):
15973 - 15980.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. J. Suffia, S. K. Reckling, C. A. Piccirillo, R. S. Goldszmid, and Y. Belkaid
Infected site-restricted Foxp3+ natural regulatory T cells are specific for microbial antigens
J. Exp. Med.,
March 20, 2006;
203(3):
777 - 788.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Miyara, Z. Amoura, C. Parizot, C. Badoual, K. Dorgham, S. Trad, D. Nochy, P. Debre, J.-C. Piette, and G. Gorochov
Global Natural Regulatory T Cell Depletion in Active Systemic Lupus Erythematosus
J. Immunol.,
December 15, 2005;
175(12):
8392 - 8400.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. R. Nicolls, L. Taraseviciene-Stewart, P. R. Rai, D. B. Badesch, and N. F. Voelkel
Autoimmunity and pulmonary hypertension: a perspective
Eur. Respir. J.,
December 1, 2005;
26(6):
1110 - 1118.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Zorn, H. T. Kim, S. J. Lee, B. H. Floyd, D. Litsa, S. Arumugarajah, R. Bellucci, E. P. Alyea, J. H. Antin, R. J. Soiffer, et al.
Reduced frequency of FOXP3+ CD4+CD25+ regulatory T cells in patients with chronic graft-versus-host disease
Blood,
October 15, 2005;
106(8):
2903 - 2911.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. W. Lim, P. Hillsamer, A. H. Banham, and C. H. Kim
Cutting Edge: Direct Suppression of B Cells by CD4+CD25+ Regulatory T Cells
J. Immunol.,
October 1, 2005;
175(7):
4180 - 4183.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Wolf, K. Hochegger, A. M. Wolf, H. F. Rumpold, G. Gastl, H. Tilg, G. Mayer, E. Gunsilius, and A. R. Rosenkranz
CD4+CD25+ Regulatory T Cells Inhibit Experimental Anti-Glomerular Basement Membrane Glomerulonephritis in Mice
J. Am. Soc. Nephrol.,
May 1, 2005;
16(5):
1360 - 1370.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. A. Ormandy, T. Hillemann, H. Wedemeyer, M. P. Manns, T. F. Greten, and F. Korangy
Increased Populations of Regulatory T Cells in Peripheral Blood of Patients with Hepatocellular Carcinoma
Cancer Res.,
March 15, 2005;
65(6):
2457 - 2464.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Balandina, S. Lecart, P. Dartevelle, A. Saoudi, and S. Berrih-Aknin
Functional defect of regulatory CD4+CD25+ T cells in the thymus of patients with autoimmune myasthenia gravis
Blood,
January 15, 2005;
105(2):
735 - 741.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. T. Rouse and S. Suvas
Regulatory Cells and Infectious Agents: Detentes Cordiale and Contraire
J. Immunol.,
August 15, 2004;
173(4):
2211 - 2215.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|
|